Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 15: Summary of NMPA/CDE Regulatory Policies for August-September 2026
Release time:2026-09-22
share:
Previous article:That's not it.....
next article:Issue 14: Monthly Regulatory Report for July-August 2026
Back to list
You may also want to read
Obtaining drug production approval for inhalation of compound ipratropium bromide solution!
2025.01.06
Good news! Hefei Leecan Pharmaceutical has once again successfully passed the new product two-in-one inspection
2026.09.20
Issue 2: Monthly Report on Pharmaceutical Regulatory Laws
2026.07.06